During the past decade, Virgilio Lima Gomez conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Virgilio Lima Gomez" are "Diabetic Retinopathy" (2 trials), "Macular Edema" (2 trials), "Clinically Significant Macular Edema" (1 trials) and "Proliferative Diabetic Retinopathy" (1 trials). Many other conditions were trialed in "Virgilio Lima Gomez" in a lesser frequency.

Most popular intervention types in "Virgilio Lima Gomez" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ketorolac" (1 trials), "Ketorolac tromethamine" (1 trials), "Nepafenac" (1 trials), "Polietilenglicol 400, propilenglicol" (1 trials) and "Polivynilic alcohol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Virgilio Lima Gomez" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Virgilio Lima Gomez". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Virgilio Lima Gomez, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Virgilio Lima Gomez, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".